TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Jordyn Tarazi
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics granted non-qualified stock options to purchase 14,100 shares for newly hired employees under their 2024 Inducement Plan, with shares vesting over a four-year period.

Insights
EPD   positive

Has increased distributions for 27 consecutive years, operates with stable cash flow from long-term fee-based contracts, and is completing a major expansion phase


ALGS   neutral

The announcement is a routine corporate action of granting stock options to new employees, indicating standard hiring and compensation practices without significant positive or negative implications